Pages that link to "Q40244491"
Jump to navigation
Jump to search
The following pages link to A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers (Q40244491):
Displaying 50 items.
- Nanotechnology: Future of Oncotherapy (Q26801067) (← links)
- Membrane domain formation-a key factor for targeted intracellular drug delivery (Q26998461) (← links)
- Targeted nanotechnology for cancer imaging (Q27010317) (← links)
- Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. (Q30436623) (← links)
- Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery (Q33385557) (← links)
- Selective targeting of nanocarriers to neutrophils and monocytes. (Q33433964) (← links)
- SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer (Q33553679) (← links)
- An integrated approach for the rational design of nanovectors for biomedical imaging and therapy (Q33679533) (← links)
- Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy (Q33802940) (← links)
- Enhanced cellular uptake of folic acid–conjugated PLGA–PEG nanoparticles loaded with vincristine sulfate in human breast cancer (Q33882801) (← links)
- Enabling individualized therapy through nanotechnology (Q33917755) (← links)
- Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures (Q34017152) (← links)
- Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes (Q34119423) (← links)
- Bioengineering strategies for designing targeted cancer therapies (Q34194191) (← links)
- Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles (Q34573279) (← links)
- In vitro assessment of antibody-conjugated gold nanorods for systemic injections (Q34706670) (← links)
- The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo. (Q35816600) (← links)
- Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis. (Q36084803) (← links)
- Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy (Q36093923) (← links)
- Antibiological barrier nanovector technology for cancer applications. (Q36903797) (← links)
- A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms (Q36949458) (← links)
- The pharmacology of regenerative medicine (Q36974665) (← links)
- Biodegradable, polymeric nanoparticle delivery systems for cancer therapy (Q36988348) (← links)
- Nanovehicular intracellular delivery systems (Q37058812) (← links)
- Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells (Q37129235) (← links)
- Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles (Q37390746) (← links)
- In vitro evaluation of functional interaction of integrin alphavbeta3 and matrix metalloprotease-2. (Q37467465) (← links)
- Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities (Q37626377) (← links)
- Liposomal cancer therapy: exploiting tumor characteristics (Q37679954) (← links)
- Enhancing biodistribution of therapeutic enzymes in vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers (Q37724781) (← links)
- Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. (Q37730633) (← links)
- Nanoparticles: a promising modality in the treatment of sarcomas. (Q37761069) (← links)
- Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. (Q37772516) (← links)
- Receptor-targeted nanocarriers for therapeutic delivery to cancer (Q37804383) (← links)
- Recent Advances in the Field of Nanometric Drug Carriers (Q37855847) (← links)
- Synthesis of architecturally well-defined nanogels via RAFT polymerization for potential bioapplications. (Q37921625) (← links)
- Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. (Q37959311) (← links)
- Dual targeting strategies with bispecific antibodies (Q37997559) (← links)
- Emerging role of radiolabeled nanoparticles as an effective diagnostic technique (Q38027231) (← links)
- CNS drug targeting: have we travelled in right path? (Q38127262) (← links)
- Guiding principles in the design of ligand-targeted nanomedicines. (Q38189490) (← links)
- Advances in targeting strategies for nanoparticles in cancer imaging and therapy (Q38255901) (← links)
- Can dual-ligand targeting enhance cellular uptake of nanoparticles? (Q38690361) (← links)
- Crossing the barrier: treatment of brain tumors using nanochain particles (Q38691508) (← links)
- The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer (Q38809044) (← links)
- Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery (Q38810713) (← links)
- Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma (Q38868191) (← links)
- Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency (Q38927345) (← links)
- Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy (Q39092356) (← links)
- In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors (Q39273796) (← links)